Skip to main content
Caplight Logo









Ossiform

Ossiform

Private
OdenseHealthcare & Life Scienceshttps://ossiform.com/

Last Round

Convertible Debt

May 30, 2025

Total Funding Raised

$13.38M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Ossiform is a medical technology company that develops and manufactures 3D printed, patient-specific, and resorbable bone implants made from tricalcium phosphate.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, 3D Printing, Biotechnology, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

patient-specific implants3D printed bone graftsbone graft substitutebioresorbable implantsbioprintingmedical 3D printingbio-inktissue engineeringbeta-tricalcium phosphateβ-TCPbone regenerationbioceramic scaffoldsorthopedic surgeryspinal fusionoral-maxillofacial surgerypoint-of-care manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ossiform Comparables

Compare Ossiform with similar companies based on industry and business-model similarity.

Ossiform comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cerhum
87%
Mimetis Biomaterials
81%
Osteopore Ltd
79%

Ossiform Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Convertible DebtMay 30, 2025
Series BOct 5, 2022
Series AMay 18, 2020
SeedJun 1, 2018
GrantJan 1, 2018

Key People

Founding team and executive leadership

Thea Wulff Olesen

Group CEO

Executive Team

Martin Bonde Jensen

CTO

Executive Team

Ossiform Investors

Notable investors and investment history

Ossiform investors
InvestorRounds
Innovation Fund DenmarkGrant
West Hill CapitalConvertible Debt, Series B, Series A
PSV TechSeed
Asimov VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors grew 37% MoM, reaching 2.1K.

  • Feb 23, 2026

    Grew 50% QoQ from 10 to 15 employees.

Ossiform Filings

Explore SEC and related filing metadata, where available.

Ossiform filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Ossiform's valuation, stock price, and market status.

Is Ossiform a public or private company?

Ossiform is a private company.

What is the current stock price of Ossiform?

Ossiform is a private company with no public stock price. No recent secondary market data is available.

How much is Ossiform worth (valuation)?

Valuation information for Ossiform is not publicly available.

Can I buy Ossiform stock?

Ossiform shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Ossiform's last funding round?

Ossiform's most recent funding round was Convertible Debt on May 30, 2025.

Who are the main investors in Ossiform?

Key investors in Ossiform include West Hill Capital, PSV Tech.

Will Ossiform IPO soon?

No public IPO plans have been announced for Ossiform.

How can I track Ossiform secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ossiform's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersOdense
Employee Range14
Year Founded2017
Last FundingMay 30, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?